Douglas W Losordo MD
Executive Vice President, Global Head of R&D, Chief Medical Officer.
Join to view full profile
420 Lexington AveNew York, NY 10011
Dr. Losordo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Medical Center-BrightonResidency, Internal Medicine, 1983 - 1986
University of Vermont College of MedicineClass of 1983- Boston Medical Center-BrightonFellowship, Cardiovascular Disease
Certifications & Licensure
NY State Medical License 2014 - 2027
OH State Medical License 2025 - 2027
IL State Medical License 2007 - 2020
MA State Medical License 1984 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACC) American College of Cardiology
Clinical Trials
Publications & Presentations
PubMed
- 39 citationsAutologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction.Timothy D Henry, C Noel Bairey Merz, Janet Wei, Michel T Corban, Odayme Quesada
Circulation. Cardiovascular Interventions. 2022-02-01 - 16 citationsCD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina.Grace L. Johnson, Timothy D. Henry, Thomas J. Povsic, Douglas W. Losordo, Ross Garberich
Stem Cells Translational Medicine. 2020-06-12 - 16 citationsAutologous CD34+ Cell Therapy for Ischemic Tissue Repair.William K. Sietsema, Atsuhiko Kawamoto, Hiroshi Takagi, Douglas W. Losordo
Circulation Journal. 2019-06-25
Press Mentions
Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical OfficerNovember 17th, 2020
AHA: Caladrius Single Injection Helps Heart Disease That Hits Women the HardestNovember 18th, 2019
Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019November 16th, 2019
Grant Support
- Small Animal Surgery And HistologyNational Heart, Lung, And Blood Institute2012
- Role Of PAI-1 In Cardiovascular Repair And FibrosisNational Heart, Lung, And Blood Institute2012
- Peptide Amphiphiles To Augment Progentitor Cell TherapiesNational Heart, Lung, And Blood Institute2012
- Mitochondrial Defects In Epcs In Diabetes And AgingNational Heart, Lung, And Blood Institute2012
- FACS Analysis And Cell SortingNational Heart, Lung, And Blood Institute2012
Professional Memberships
- Fellow
- Fellow
- Society for Cardiovascular Angiography and InterventionsFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
